Becton Dickinson (BDX) cash: $740M
Becton Dickinson held $740M in cash and cash equivalents on Dec 31, 2025, up 4.1% from $711M a year earlier.
From Becton Dickinson's filings with the SEC · Read the filing · BDX stock page
Becton Dickinson cash by year
#681 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $740M | +4% |
| Dec 31, 2024 | $711M | -40% |
| Dec 31, 2023 | $1.2B | +93% |
| Dec 31, 2022 | $612M | -68% |
| Dec 31, 2021 | $1.9B | – |
Cash of similar companies
Companies in the same industry as Becton Dickinson, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Dexcom | $918M | Dec 31, 2025 |
| Solventum | $878M | Dec 31, 2025 |
| West Pharmaceutical Services | $791M | Dec 31, 2025 |
| Becton Dickinson | $740M | Dec 31, 2025 |
| Insulet | $716M | Dec 31, 2025 |
| Globus Medical | $526M | Dec 31, 2025 |
| Merit Medical Systems | $446M | Dec 31, 2025 |
Questions and answers
What is Becton Dickinson's cash?
Becton Dickinson held $740M in cash and cash equivalents on Dec 31, 2025, up 4.1% from $711M a year earlier.
Numbers as reported in Becton Dickinson's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology